Patents Assigned to Dispersa AG
  • Patent number: 4829083
    Abstract: The invention relates to the stabilization of mercury-containing preservatives in liquid or gel-form ophthalmic medicaments. This stabilization against chemical decomposition after the preservative has become deposited on the inner walls of the plastics containers is achieved by adding to the formulation 2-amino-2-hydroxymethyl-1,3-propanediol or a homologue thereof having up to 10 carbon atoms.
    Type: Grant
    Filed: April 14, 1987
    Date of Patent: May 9, 1989
    Assignee: Dispersa AG
    Inventor: Johann Doulakas
  • Patent number: 4829088
    Abstract: The invention relates to an ophthalmic medicament containing diclofenac-sodium in aqueous solution. Owing to the addition of a specific stabilizer, the medicament has excellent stability against chemical decomposition of the active ingredient and outstanding preservation properties and is tolerated very well by the eye.
    Type: Grant
    Filed: April 14, 1987
    Date of Patent: May 9, 1989
    Assignee: Dispersa AG
    Inventor: Johann Doulakas
  • Patent number: 4415564
    Abstract: Pharmaceutical preparations for treating glaucoma and ocular hypertension, containing guanethidine or a pharmaceutically acceptable salt thereof and a specific .beta..sub.2 -receptor agonist in relative quantities of 20:1 to 1:5 in an aqueous solution.
    Type: Grant
    Filed: June 21, 1982
    Date of Patent: November 15, 1983
    Assignee: Dispersa AG
    Inventors: Giancesare Gamba, Luciano Bonomi